Dendreon shares slide on Provenge delay worry (DNDN)

Posted in block volume, General 
June 23rd, 2009

Dendreon (DNDN) shares are trading about 4% lower on a sudden surge in volume as of about 10 a.m. Eastern this morning.

Market participants appear to be questioning if the timing of a plant buildout laid out in a filing late yesterday means that the company’s Provenge drug could be delayed.  — Mike Tarsala

For details, go to biohealthinvestor.com.

 

Comments are closed

-->